Literature DB >> 8905407

IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells.

C Hsu1, D MacGlashan.   

Abstract

We have examined 3-week-old alcian blue positive cells (putatively mast cells) derived from mouse bone marrow for their expression of Fc epsilon RI. Using an indirect method of sensitizing the cells with immunoglobulin E (IgE) antibody (anti-DNP IgE) and detecting the level of bound IgE antibody by flow cytometry, we found that prolonged culture (1-5 days) with IgE, but not IgG, increased the total receptor density 6 +/- 1.9 fold. During the same period, histamine release in response to antigen (DNP-HSA) increased approximately 6-fold while the cell's response to either thrombin or ionomycin remained constant. The greatest up-regulation occurred in the first 2 days of culture. Using 2.4G2 to detect Fc epsilon RII RIII, we could not detect any up-regulation of this receptor. Culturing the cells for 1 h after sensitization did not result in any loss of cell surface IgE, suggesting a reasonably high affinity binding similar to that expected for Fc epsilon RI. This up-regulation was completely inhibited by co-culture with 2 micrograms/ml cycloheximide. These data suggest that IgE is capable of inducing a significant, protein synthesis, dependent up-regulation of its own high affinity receptor on mast cells/basophils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905407     DOI: 10.1016/0165-2478(96)02599-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  31 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.

Authors:  Jayapal Manikandan; Narasimhan Kothandaraman; Manoor Prakash Hande; Peter Natesan Pushparaj
Journal:  Cell Mol Life Sci       Date:  2011-12-07       Impact factor: 9.261

3.  Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI.

Authors:  Jiro Kitaura; Jinming Song; Mindy Tsai; Koichi Asai; Mari Maeda-Yamamoto; Attila Mocsai; Yuko Kawakami; Fu-Tong Liu; Clifford A Lowell; B George Barisas; Stephen J Galli; Toshiaki Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

Review 4.  IgE and FcepsilonRI regulation.

Authors:  Donald MacGlashan
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

Review 5.  Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.

Authors:  Toshiaki Kawakami; Jiro Kitaura
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 6.  Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Authors:  Zhou Zhu; Sun Young Oh; You Sook Cho; Li Zhang; Yoon-Keun Kim; Tao Zheng
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

7.  The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.

Authors:  M Huber; C D Helgason; J E Damen; L Liu; R K Humphries; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

8.  Allergen-independent immunomodulatory activities of immunoglobulin E.

Authors:  A A Horner; T Kawakami
Journal:  Clin Exp Allergy       Date:  2009-01-22       Impact factor: 5.018

9.  Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice.

Authors:  M Haak-Frendscho; R Saban; R L Shields; P M Jardieu
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

10.  Rabaptin-5 regulates receptor expression and functional activation in mast cells.

Authors:  Eon J Rios; Adrian M Piliponsky; Chisei Ra; Janet Kalesnikoff; Stephen J Galli
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.